Endocyte Reports Third Quarter 2016 Financial Results
November 09, 2016 16:01 ET
|
Endocyte, inc
- Confirmed Maximum Dose for EC1169 and Initiated Expansion Phase in Prostate Cancer Patients -- First Confirmed RECIST Partial Response Observed in EC1169 Dose Escalation Reported at European Society...
Endocyte Announces Third Quarter 2016 Earnings Conference Call
November 02, 2016 16:01 ET
|
Endocyte, inc
WEST LAFAYETTE, Ind., Nov. 02, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc., (NASDAQ:ECYT) announced today that the company will host a conference call on Wednesday, Nov. 9th, at 4:30 p.m. EST to discuss...
Endocyte to Present at the 25th Annual Credit Suisse Healthcare Conference
November 01, 2016 16:01 ET
|
Endocyte, inc
WEST LAFAYETTE, Ind., Nov. 01, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
Endocyte Presents Data on Two Lead Clinical Programs at European Society for Medical Oncology (ESMO) 2016 Congress
October 10, 2016 08:00 ET
|
Endocyte, inc
WEST LAFAYETTE, Ind., Oct. 10, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
Endocyte Announces Presentations at the European Society for Medical Oncology (ESMO)
September 29, 2016 16:01 ET
|
Endocyte, inc
WEST LAFAYETTE, Ind., Sept. 29, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
Endocyte to Present at the Ladenburg Thalmann 2016 Healthcare Conference
September 20, 2016 16:01 ET
|
Endocyte, inc
WEST LAFAYETTE, Ind., Sept. 20, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
Endocyte Announces Presentations at the 252nd American Chemical Society National Meeting & Exposition
August 15, 2016 16:01 ET
|
Endocyte, inc
WEST LAFAYETTE, Ind., Aug. 15, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
Endocyte to Present at the 2016 Wedbush PacGrow Healthcare Conference
August 09, 2016 16:01 ET
|
Endocyte, inc
WEST LAFAYETTE, Ind., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
Endocyte Reports Second Quarter 2016 Financial Results
August 04, 2016 16:01 ET
|
Endocyte, inc
– Reached Maximum Tolerated Dose in Twice Weekly Dosing Schedule with EC1456 – – Initiating EC1456 Expansion Cohort in Targeted Population of Folate Receptor-Positive Non-Small Cell Lung...
Endocyte Announces Second Quarter 2016 Earnings Conference Call
July 28, 2016 16:01 ET
|
Endocyte, inc
WEST LAFAYETTE, Ind., July 28, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc., (NASDAQ:ECYT) announced today that the company will host a conference call on Thursday, August 4th, at 4:30 p.m. EDT to...